182 related articles for article (PubMed ID: 23263830)
21. CD151 expression can predict cancer progression in clear cell renal cell carcinoma.
Yoo SH; Lee K; Chae JY; Moon KC
Histopathology; 2011 Jan; 58(2):191-7. PubMed ID: 21323946
[TBL] [Abstract][Full Text] [Related]
22. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
[TBL] [Abstract][Full Text] [Related]
23. Low NR3C2 levels correlate with aggressive features and poor prognosis in non-distant metastatic clear-cell renal cell carcinoma.
Zhao Z; Zhang M; Duan X; Deng T; Qiu H; Zeng G
J Cell Physiol; 2018 Oct; 233(10):6825-6838. PubMed ID: 29693713
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.
Pan D; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J
Jpn J Clin Oncol; 2015 Feb; 45(2):202-9. PubMed ID: 25420690
[TBL] [Abstract][Full Text] [Related]
25. Homeodomain interacting protein kinase-2 phosphorylates FOXM1 and promotes FOXM1-mediated tumor growth in renal cell carcinoma.
Liu F; Li N; Liu Y; Zhang J; Zhang J; Wang Z
J Cell Biochem; 2019 Jun; 120(6):10391-10401. PubMed ID: 30609136
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of forkhead box protein M1 (FOXM1) in ovarian cancer correlates with poor patient survival and contributes to paclitaxel resistance.
Zhao F; Siu MK; Jiang L; Tam KF; Ngan HY; Le XF; Wong OG; Wong ES; Gomes AR; Bella L; Khongkow P; Lam EW; Cheung AN
PLoS One; 2014; 9(11):e113478. PubMed ID: 25411964
[TBL] [Abstract][Full Text] [Related]
27. TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma.
Pan Q; Cheng G; Liu Y; Xu T; Zhang H; Li B
Int J Oncol; 2020 May; 56(5):1101-1114. PubMed ID: 32319572
[TBL] [Abstract][Full Text] [Related]
28. The expression of Eg5 predicts a poor outcome for patients with renal cell carcinoma.
Sun D; Lu J; Ding K; Bi D; Niu Z; Cao Q; Zhang J; Ding S
Med Oncol; 2013 Mar; 30(1):476. PubMed ID: 23371254
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of immunohistochemical staining for myoferlin in clear cell renal cell carcinoma and its association with epidermal growth factor receptor expression.
Jung M; Lee C; Park JH; Moon KC
Urol Oncol; 2019 Nov; 37(11):812.e9-812.e16. PubMed ID: 31421995
[TBL] [Abstract][Full Text] [Related]
30. FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis.
Liang SK; Hsu CC; Song HL; Huang YC; Kuo CW; Yao X; Li CC; Yang HC; Hung YL; Chao SY; Wu SC; Tsai FR; Chen JK; Liao WN; Cheng SC; Tsou TC; Wang IC
Oncogene; 2021 Jul; 40(30):4847-4858. PubMed ID: 34155349
[TBL] [Abstract][Full Text] [Related]
31. Integration of NRP1, RGS5, and FOXM1 expression, and tumour necrosis, as a postoperative prognostic classifier based on molecular subtypes of clear cell renal cell carcinoma.
Yoshida T; Ohe C; Ikeda J; Atsumi N; Saito R; Taniguchi H; Ohsugi H; Sugi M; Tsuta K; Matsuda T; Kinoshita H
J Pathol Clin Res; 2021 Nov; 7(6):590-603. PubMed ID: 34212534
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of ALDH1A1 protein is associated with poor prognosis in clear cell renal cell carcinoma.
Wang K; Chen X; Zhan Y; Jiang W; Liu X; Wang X; Wu B
Med Oncol; 2013; 30(2):574. PubMed ID: 23585015
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma.
Ni D; Ma X; Li HZ; Gao Y; Li XT; Zhang Y; Ai Q; Zhang P; Song EL; Huang QB; Fan Y; Zhang X
Clin Cancer Res; 2014 Apr; 20(7):1779-90. PubMed ID: 24486593
[TBL] [Abstract][Full Text] [Related]
34. Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.
White-Al Habeeb NM; Di Meo A; Scorilas A; Rotondo F; Masui O; Seivwright A; Gabril M; Girgis AH; Jewett MA; Yousef GM
Clin Exp Metastasis; 2015 Aug; 32(6):531-41. PubMed ID: 26037892
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of human leukocyte antigen class I (HLA-I) is associated with poor prognosis in patients with clear cell renal cell carcinoma.
Yuan J; Liu S; Yu Q; Lin Y; Bi Y; Wang Y; An R
Acta Histochem; 2013 Jun; 115(5):470-4. PubMed ID: 23245688
[TBL] [Abstract][Full Text] [Related]
36. Decreased Expression of SETD2 Predicts Unfavorable Prognosis in Patients With Nonmetastatic Clear-Cell Renal Cell Carcinoma.
Liu W; Fu Q; An H; Chang Y; Zhang W; Zhu Y; Xu L; Xu J
Medicine (Baltimore); 2015 Nov; 94(45):e2004. PubMed ID: 26559293
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of FOXM1 is associated with poor prognosis and clinicopathologic stage of pancreatic ductal adenocarcinoma.
Xia JT; Wang H; Liang LJ; Peng BG; Wu ZF; Chen LZ; Xue L; Li Z; Li W
Pancreas; 2012 May; 41(4):629-35. PubMed ID: 22249132
[TBL] [Abstract][Full Text] [Related]
38. S100A8 Expression May Have a Prognostic Value in CCRCC Reflecting TNM Staging and Fuhrman Nuclear Grade.
An HJ; Koh HM; Song DH
Anticancer Res; 2019 Sep; 39(9):4681-4685. PubMed ID: 31519567
[TBL] [Abstract][Full Text] [Related]
39. High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma.
Pan D; Xu L; Liu H; Zhang W; Liu W; Liu Y; Fu Q; Xu J
Cancer Sci; 2015 May; 106(5):592-7. PubMed ID: 25702890
[TBL] [Abstract][Full Text] [Related]
40. Involvement of FoxM1 in non-small cell lung cancer recurrence.
Xu N; Wu SD; Wang H; Wang Q; Bai CX
Asian Pac J Cancer Prev; 2012; 13(9):4739-43. PubMed ID: 23167412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]